| Literature DB >> 35647560 |
Qiang Wang1, Suhuan Mei1, Perumal Manivel1, Haile Ma1,2, Xiumin Chen1,2,3.
Abstract
Plant extracts have been widely used to green synthesize zinc oxide nanoparticles (ZnO NPs); however, how the combination of ultrasound and coffee leaf extract (CLE) affects the structure characteristics and the yield of ZnO NPs remains unknown. In this study, we used CLE to green synthesize ZnO NPs with the help of ultrasound. The highest yield (43.59 ± 0.13%) of ZnO NPs was obtained under the optimal processing conditions of pH = 8.0, mass ratio of coffee leaves to C4H6O4Zn•2H2O = 1.71, ultrasound time = 10 min, ultrasound frequency = 28/40 kHz, ultrasound power = 180 W, and synthesis temperature = 30 °C. The as-synthesized ZnO NPs were characterized by UV-Vis, SEM, EDX, TEM, FTIR, XRD, and zeta potential analyses. SEM and TEM analyses revealed that ZnO NPs synthesized using ultrasound-assisted method were spherical with an average particle size of 8.29 ± 1.38 nm, which was smaller than ZnO NPs synthesized without ultrasound treatment (10.48 ± 1.57 nm) and the chemically synthesized ZnO NPs (17.15 ± 2.84 nm). HPLC analysis showed that the phenolic compounds in coffee leaves, especially 5-CQA, were the main reductants and chelating agents for ZnO NPs synthesis. The synthesized ZnO NPs were used to load mangiferin, which was control released under pH 7.4 over 132 h. Our study provides an easy and eco-friendly method using CLE assisted with ultrasound for green synthesis of ZnO NPs which can be used as nanocarriers to control release of mangiferin.Entities:
Keywords: Coffee leaf; Drug loading; Green synthesis; Mangiferin; Ultrasound; ZnO NPs
Year: 2022 PMID: 35647560 PMCID: PMC9133588 DOI: 10.1016/j.crfs.2022.05.002
Source DB: PubMed Journal: Curr Res Food Sci ISSN: 2665-9271
The impacts of ultrasonic conditions on the yield of ZnO NPs.
| Ultrasonic conditions | Levels | Yield/% |
|---|---|---|
| pH | 7.0 | 4.58 ± 0.31d |
| 7.5 | 24.99 ± 0.33c | |
| 8.0 | 36.26 ± 0.89a | |
| 8.5 | 33.94 ± 0.32b | |
| 9.0 | 34.08 ± 1.58ab | |
| 0.23 : 1 | 34.49 ± 0.38e | |
| 0.46 : 1 | 36.00 ± 0.18de | |
| 0.68 : 1 | 36.26 ± 0.89cd | |
| 0.91 : 1 | 39.20 ± 0.42ab | |
| 1.14 : 1 | 39.64 ± 0.31ab | |
| 1.37 : 1 | 39.83 ± 0.62a | |
| 1.71 : 1 | 40.43 ± 0.99a | |
| 2.28 : 1 | 37.98 ± 0.59bc | |
| 10 | 39.44 ± 1.40a | |
| 20 | 39.51 ± 0.25a | |
| 30 | 40.43 ± 0.99a | |
| 40 | 40.91 ± 1.04a | |
| 50 | 40.67 ± 0.43a | |
| 20 | 40.42 ± 1.7ab | |
| 28 | 40.78 ± 0.73ab | |
| 40 | 39.44 ± 1.40ab | |
| 20/28 | 38.36 ± 0.77bc | |
| 20/40 | 40.63 ± 0.69ab | |
| 28/40 | 41.40 ± 0.58a | |
| 20/28/40 | 36.62 ± 0.06c | |
| 60 | 38.82 ± 0.37b | |
| 120 | 40.13 ± 0.66ab | |
| 180 | 41.40 ± 0.58a | |
| 240 | 40.88 ± 0.04a | |
| 300 | 41.02 ± 0.62a | |
| 20 | 41.34 ± 0.21b | |
| 25 | 41.56 ± 0.17b | |
| 30 | 43.59 ± 0.13a | |
| 40 | 41.83 ± 0.25ab | |
| 50 | 41.40 ± 0.58b | |
| 60 | 41.66 ± 1.58ab | |
| 70 | 43.23 ± 0.82ab |
Data were expressed as mean ± SD; Means do not share letters denote significant difference at P < 0.05.
The ultrasound conditions are as follows: mass ratio = 0.68, ultrasound time = 30 min, ultrasound frequency = 40 kHz, ultrasound power = 180 W, synthesis temperature = 50 °C, pH = 7.0, 7.5, 8.0, 8.5, 9.0.
The ultrasound conditions are as follows: pH = 8.0, ultrasound time = 30 min, ultrasound frequency = 40 kHz, ultrasound power = 180 W, synthesis temperature = 50 °C, mass ratio = 0.23, 0.46, 0.68, 0.91, 1.14, 1.37, 1.71, 2.28.
The ultrasound conditions are as follows: pH = 8.0, mass ratio = 1.71, ultrasound frequency = 40 kHz, ultrasound power = 180 W, synthesis temperature = 50 °C, ultrasound time = 10, 20, 30, 40, 50 min.
The ultrasound conditions are as follows: pH = 8.0, mass ratio = 1.71, ultrasound time = 10 min, ultrasound power = 180 W, synthesis temperature = 50 °C, ultrasound frequency = 20, 28, 40, 20/28, 20/40, 28/40, 20/28/40 kHz.
The ultrasound conditions are as follows: pH = 8.0, mass ratio = 1.71, ultrasound time = 10 min, ultrasound frequency = 28/40 kHz, synthesis temperature = 50 °C, ultrasound power = 60, 120, 180, 240, 300 W.
The ultrasound conditions are as follows: pH = 8.0, mass ratio = 1.71, ultrasound time = 10 min, ultrasound frequency = 28/40 kHz, ultrasound power = 180 W, synthesis temperature = 20, 25, 30, 40, 50, 60, 70 °C.
Total phenolic content and phytochemical compositions in the coffee leaf extract before and after ZnO NPs synthesis.
| Treatment | TPC (mg gallic acid/g leaf) | Phytochemical compositions (μg/mL) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mangiferin | Rutin | Trigonelline | Caffeine | 5-CQA | 3,4-diCQA | 3,5-diCQA | 4,5-diCQA | |||
| 79.82 ± 6.38* | 95.84 ± 2.92* | 78.73 ± 2.78* | 244.78 ± 7.55* | 192.15 ± 9.30* | 355.79 ± 12.23* | 28.65 ± 0.83* | 53.95 ± 1.70* | 19.27 ± 0.29* | ||
| 1.44 ± 0.39 | 4.45 ± 0.29 | ND | 156.67 ± 13.13 | 140.19 ± 8.92 | 1.38 ± 2.39 | ND | ND | ND | ||
| 98.16 ± 0.65† | 95.36 ± 0.16 | 100.00 ± 0.00 | 36.06 ± 3.60† | 27.08 ± 1.13† | 99.62 ± 0.65† | 100.00 ± 0.00 | 100.00 ± 0.00 | 100.00 ± 0.00 | ||
| 79.82 ± 6.38# | 95.84 ± 2.92# | 78.73 ± 2.78# | 244.78 ± 7.55# | 192.15 ± 9.30# | 355.79 ± 12.23# | 28.65 ± 0.83# | 53.95 ± 1.70# | 19.27 ± 0.92# | ||
| 2.24 ± 0.10 | 4.51 ± 0.00 | ND | 176.59 ± 3.60 | 156.67 ± 3.96 | 4.07 ± 0.11 | ND | ND | ND | ||
| 97.10 ± 0.25 | 95.29 ± 0.15 | 100.00 ± 0.00 | 27.79 ± 3.50 | 18.47 ± 2.06 | 98.85 ± 0.02 | 100.00 ± 0.00 | 100.00 ± 0.00 | 100.00 ± 0.00 | ||
* Denote significant differences (P < 0.05) between samples before and after ZnO NPs synthesis under ultrasound treatment.
# Denote significant differences (P < 0.05) between samples before and after ZnO NPs synthesis without ultrasound treatment.
† Denote significant differences (P < 0.05) between the changes of samples with and without ultrasound treatment.
Data were shown as means ± SD.
ND = Not detectable.
ZnO NPs synthesis with ultrasound treatment under optimum conditions.
ZnO NPs synthesis without ultrasound treatment under optimum conditions.
Fig. 1HPLC chromatograph of phytochemical compositions in reaction mixture at 257 nm a, Before synthesis; b, After ultrasound-assisted synthesis; c, After non-ultrasound-assisted synthesis.
Fig. 2UV–Vis spectrum of the ZnO NPs.
Fig. 3SEM images and EDX spectrum of ZnO NPs. a, Ultrasound-assisted synthesis using coffee leaf extract; b, Non-ultrasound-assisted synthesis using coffee leaf extract; c, Chemical synthesis; d, Mangiferin loaded ZnO NPs. a1, b1, c1, d1 with magnification 100,000×; a2, b2, c2, d2 with magnification 50,000×. a3, b3, c3, d3 are EDX spectrum of the corresponding ZnO NPs.
Fig. 4TEM images and the size distribution of ZnO NPs. a, Ultrasound-assisted synthesis using coffee leaf extract; b, Non-ultrasound-assisted synthesis using coffee leaf extract; c, Chemical synthesis. 1 represents TEM images and 2 represents frequency distribution histograms of size.
Fig. 5XRD patterns for the ZnO NPs.
Fig. 6FTIR spectrum of ZnO NPs.
Fig. 7Release profile of mangiferin loaded ZnO NPs.